We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-29.01%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.61B
AUM Growth
-$5.21B
Cap. Flow
-$1.94B
Cap. Flow %
-34.52%
Top 10 Hldgs %
32.81%
Holding
298
New
9
Increased
35
Reduced
202
Closed
49

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$14.5M
2
TRUP icon
Trupanion
TRUP
+$10.4M
3
DE icon
Deere & Co
DE
+$9.85M
4
SNOW icon
Snowflake
SNOW
+$9.2M
5
TECK icon
Teck Resources
TECK
+$7.87M

Top Sells

Rank Stock Value
1
SHOP icon
Shopify
SHOP
+$79.6M
2
TSLA icon
Tesla
TSLA
+$77M
3
TDOC icon
Teladoc Health
TDOC
+$62.8M
4
SPOT icon
Spotify
SPOT
+$62M
5
CVNA icon
Carvana
CVNA
+$60.4M

Sector Composition

Rank Sector Weight
1 Technology 32.75%
2 Consumer Discretionary 22.31%
3 Healthcare 18.1%
4 Communication Services 9.01%
5 Industrials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRTC icon
176
iRhythm Holdings
IRTC
$3.69B
$1.88M 0.03%
17,404
-77
-0.4% -$10.2K
KYMR icon
177
Kymera Therapeutics
KYMR
$9.41B
$1.87M 0.03%
95,073
-19,433
-17% -$454K
GTX icon
178
Garrett Motion
GTX
$4.78B
$1.84M 0.03%
238,169
-510,890
-68% -$3.46M
AUPH icon
179
Aurinia Pharmaceuticals
AUPH
$2.15B
$1.81M 0.03%
179,966
-17,969
-9% -$201K
JPM icon
180
JPMorgan Chase
JPM
$937B
$1.78M 0.03%
15,776
-18
-0.1% -$2.23K
TLSI icon
181
TriSalus Life Sciences
TLSI
$294M
$1.7M 0.03%
172,864
-679,216
-80% -$6.67M
APEN
182
DELISTED
Apollo Endosurgery, Inc.
APEN
$1.69M 0.03%
462,889
-43,469
-9% -$205K
ATVI
183
DELISTED
Activision Blizzard
ATVI
$1.59M 0.03%
20,480
-4
-0% -$311
GFS icon
184
GlobalFoundries
GFS
$23.5B
$1.45M 0.03%
35,951
-31
-0.1% -$1.64K
VZLA
185
Vizsla Silver
VZLA
$1.34B
$1.42M 0.03%
1,382,365
-94,135
-6% -$143K
ALEC icon
186
Alector
ALEC
$228M
$1.42M 0.03%
139,393
-44,879
-24% -$448K
VEEV icon
187
Veeva Systems
VEEV
$43.2B
$1.34M 0.02%
6,771
+72
+1% +$13.2K
IMPL
188
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$1.28M 0.02%
+137,394
New +$1M
FRXB
189
DELISTED
Forest Road Acquisition Corp. II
FRXB
$1.26M 0.02%
128,726
-189,571
-60% -$1.85M
CP icon
190
Canadian Pacific Kansas City
CP
$78.3B
$1.21M 0.02%
17,381
+2
+0% +$145
BRK.B icon
191
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.19M 0.02%
4,348
-835
-16% -$262K
ARLO icon
192
Arlo Technologies
ARLO
$1.45B
$1.18M 0.02%
187,478
-3,111
-2% -$22.8K
OLK
193
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$1.13M 0.02%
74,449
+142
+0.2% +$1.84K
SHW icon
194
Sherwin-Williams
SHW
$78.5B
$1.11M 0.02%
4,975
+12
+0.2% +$3.08K
PROF
195
Profound Medical
PROF
$208M
$1.07M 0.02%
146,515
-16,732
-10% -$132K
WOLF icon
196
Wolfspeed
WOLF
$1.25B
$1.05M 0.02%
16,505
SONO icon
197
Sonos
SONO
$1.85B
$1.04M 0.02%
57,786
+76
+0.1% +$1.7K
ASPN icon
198
Aspen Aerogels
ASPN
$403M
$999K 0.02%
101,142
-7,788
-7% -$157K
LLY icon
199
Eli Lilly
LLY
$1.01T
$974K 0.02%
+3,003
New +$901K
SBUX icon
200
Starbucks
SBUX
$110B
$941K 0.02%
12,323
-143,861
-92% -$11M

Similar funds

Gilder Gagnon Howe & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Gilder Gagnon Howe & Co held 298 positions worth $5.61B, down 48% from $10.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $1.94B in Q2 2022, closing 49 positions and reducing 202 holdings. Its most notable exit was Teladoc Health, an estimated $62.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Teck Resources worth $6.1M.

  • Gilder Gagnon Howe & Co's largest Q2 2022 buy was Teck Resources: 199,396 shares worth $6.1M.
  • Gilder Gagnon Howe & Co added most to CrowdStrike in Q2 2022, an estimated $14.5M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2022 reduction was Shopify, cutting an estimated $79.6M.
  • Gilder Gagnon Howe & Co fully exited Teladoc Health in Q2 2022, selling an estimated $62.8M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 33% of its $5.61B portfolio in Q2 2022.
  • Gilder Gagnon Howe & Co opened 9 new positions and closed 49 in Q2 2022.
  • Gilder Gagnon Howe & Co's portfolio value fell 48% quarter-over-quarter to $5.61B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2022, filed 15 Aug 2022.